{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T12:22:10Z","timestamp":1792153330296,"version":"4.4.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.ejpb.2022.01.009","type":"journal-article","created":{"date-parts":[[2022,2,8]],"date-time":"2022-02-08T20:50:53Z","timestamp":1644353453000},"page":"101-111","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":73,"special_numbering":"C","title":["Elucidating inhaled liposome surface charge on its interaction with biological barriers in the lung"],"prefix":"10.1016","volume":"172","author":[{"given":"Jing","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruxiao","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirui","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ejpb.2022.01.009_b0005","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.drudis.2019.09.023","article-title":"Physicochemical properties affecting the fate of nanoparticles in pulmonary drug delivery","volume":"25","author":"Liu","year":"2020","journal-title":"Drug Discov. Today"},{"issue":"7","key":"10.1016\/j.ejpb.2022.01.009_b0010","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1007\/s11095-016-1911-7","article-title":"Liposomal aerosols of Nitric Oxide (NO) donor as a long-acting substitute for the ultra-short-acting inhaled NO in the treatment of PAH","volume":"33","author":"Nahar","year":"2016","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2022.01.009_b0015","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1023\/A:1018989423909","article-title":"Factors affecting the release rate of terbutaline from liposome formulations after intratracheal instillation in the guinea pig","volume":"9","author":"Fielding","year":"1992","journal-title":"Pharm. Res."},{"issue":"1","key":"10.1016\/j.ejpb.2022.01.009_b0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-5173(98)00398-6","article-title":"Pulmonary distribution and clearance of two beclomethasone liposome formulations in healthy volunteers","volume":"181","author":"Saari","year":"1999","journal-title":"Int. J. Pharm."},{"issue":"23","key":"10.1016\/j.ejpb.2022.01.009_b0025","doi-asserted-by":"crossref","first-page":"6786","DOI":"10.1039\/D0BM01529F","article-title":"Exploring the influence of inhaled liposome membrane fluidity on its interaction with pulmonary physiological barriers","volume":"8","author":"Zhao","year":"2020","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.ejpb.2022.01.009_b0030","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.addr.2008.11.002","article-title":"Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues","volume":"61","author":"Lai","year":"2009","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2022.01.009_b0035","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.ejpb.2019.09.020","article-title":"The Lord of the Lungs: the essential role of pulmonary surfactant upon inhalation of nanoparticles","volume":"144","author":"Garcia-Mouton","year":"2019","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2022.01.009_b0040","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1126\/science.1152066","article-title":"Membrane phosphatidylserine regulates surface charge and protein localization","volume":"319","author":"Yeung","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.ejpb.2022.01.009_b0045","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.ejpb.2014.04.001","article-title":"The surface charge of liposomal adjuvants is decisive for their interactions with the Calu-3 and A549 airway epithelial cell culture models","volume":"87","author":"Ingvarsson","year":"2014","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2022.01.009_b0050","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1021\/js9604218","article-title":"Disposition of aerosolized liposomal amphotericin B","volume":"86","author":"Lambros","year":"1997","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2022.01.009_b0055","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jconrel.2018.03.011","article-title":"Enhanced uptake in 2D- and 3D-lung cancer cell models of redox responsive PEGylated nanoparticles with sensitivity to reducing extra- and intracellular environments","volume":"277","author":"Conte","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2022.01.009_b0060","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1080\/17435390.2019.1570373","article-title":"Cell membrane disintegration and extracellular vesicle release in a model of different size and charge PAMAM dendrimers effects on cultured endothelial cells","volume":"13","author":"Patel","year":"2019","journal-title":"Nanotoxicology"},{"key":"10.1016\/j.ejpb.2022.01.009_b0065","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.1016\/j.biomaterials.2009.04.009","article-title":"NanoGenotoxicology: the DNA damaging potential of engineered nanomaterials","volume":"30","author":"Singh","year":"2009","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejpb.2022.01.009_b0070","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1002\/jat.3247","article-title":"Influence of the surface charge of PLGA nanoparticles on their in vitro genotoxicity, cytotoxicity, ROS production and endocytosis","volume":"36","author":"Platel","year":"2016","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.ejpb.2022.01.009_b0075","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/S0142-9612(02)00445-3","article-title":"In vitro cytotoxicity testing of polycations: influence of polymer structure on cell viability and hemolysis","volume":"24","author":"Fischer","year":"2003","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejpb.2022.01.009_b0080","series-title":"Advances in Biomembranes and Lipid Self-Assembly","first-page":"67","article-title":"Chapter three \u2013 tuning the membrane fluidity of liposomes for desirable in vivo fate with enhanced drug delivery","author":"Zhao","year":"2021"},{"key":"10.1016\/j.ejpb.2022.01.009_b0085","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.bbrc.2011.12.134","article-title":"Selective accumulation and growth inhibition of hybrid liposomes to human hepatocellular carcinoma cells in relation to fluidity of plasma membranes","volume":"418","author":"Komizu","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejpb.2022.01.009_b0090","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.ijpharm.2017.09.018","article-title":"Physicochemical properties of mucus and their impact on transmucosal drug delivery","volume":"532","author":"Leal","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2022.01.009_b0095","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1016\/j.biomaterials.2013.01.064","article-title":"Nanoparticle diffusion in respiratory mucus from humans without lung disease","volume":"34","author":"Schuster","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejpb.2022.01.009_b0100","doi-asserted-by":"crossref","first-page":"4136","DOI":"10.1021\/bm201226x","article-title":"Biodegradable nanoparticles meet the bronchial airway barrier: how surface properties affect their interaction with mucus and epithelial cells","volume":"12","author":"Mura","year":"2011","journal-title":"Biomacromolecules"},{"issue":"4","key":"10.1016\/j.ejpb.2022.01.009_b0105","first-page":"326","article-title":"Enhanced digestion inhibition and mucus penetration of F127-modified self-nanoemulsions for improved oral delivery","volume":"13","author":"Song","year":"2018","journal-title":"Asian J. Pharm. Sci."},{"issue":"1-2","key":"10.1016\/j.ejpb.2022.01.009_b0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2013.04.002","article-title":"Comparative study of Pluronic\u00ae F127-modified liposomes and chitosan-modified liposomes for mucus penetration and oral absorption of cyclosporine A in rats","volume":"449","author":"Chen","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2022.01.009_b0115","series-title":"Controlled Pulmonary Drug Delivery","first-page":"143","article-title":"Controlled transport for pulmonary drug delivery","author":"Fiegel","year":"2011"},{"issue":"12","key":"10.1016\/j.ejpb.2022.01.009_b0120","doi-asserted-by":"crossref","first-page":"10525","DOI":"10.1021\/nn4054683","article-title":"Physicochemical properties of nanoparticles regulate translocation across pulmonary surfactant monolayer and formation of lipoprotein corona","volume":"7","author":"Hu","year":"2013","journal-title":"ACS Nano"},{"issue":"12","key":"10.1016\/j.ejpb.2022.01.009_b0125","doi-asserted-by":"crossref","first-page":"2100067","DOI":"10.1002\/smsc.202100067","article-title":"Systematic analysis of composition, interfacial performance and effects of pulmonary surfactant preparations on cellular uptake and cytotoxicity of aerosolized nanomaterials","volume":"1","author":"Huck","year":"2021","journal-title":"Small Sci."},{"key":"10.1016\/j.ejpb.2022.01.009_b0130","doi-asserted-by":"crossref","first-page":"19436","DOI":"10.1038\/s41598-020-76332-7","article-title":"Pulmonary surfactant inhibition of nanoparticle uptake by alveolar epithelial cells","volume":"10","author":"Radiom","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejpb.2022.01.009_b0135","doi-asserted-by":"crossref","first-page":"5764","DOI":"10.1039\/C8SM00925B","article-title":"The role of surface charge in the interaction of nanoparticles with model pulmonary surfactants","volume":"14","author":"Mousseau","year":"2018","journal-title":"Soft Matter"},{"key":"10.1016\/j.ejpb.2022.01.009_b0140","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1016\/j.biomaterials.2013.01.030","article-title":"Intracellular delivery and antitumor effects of pH-sensitive liposomes based on zwitterionic oligopeptide lipids","volume":"34","author":"Mo","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejpb.2022.01.009_b0145","doi-asserted-by":"crossref","first-page":"3642","DOI":"10.1021\/acs.molpharmaceut.7b00997","article-title":"Cationic polymeric nanoparticle delivering CCR2 siRNA to inflammatory monocytes for tumor microenvironment modification and cancer therapy","volume":"15","author":"Shen","year":"2018","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejpb.2022.01.009_b0150","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1089\/jamp.2009.0797","article-title":"Update on macrophage clearance of inhaled micro- and nanoparticles","volume":"23","author":"Geiser","year":"2010","journal-title":"J. Aerosol Med. Pulmon. Drug Deliv."},{"key":"10.1016\/j.ejpb.2022.01.009_b0155","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1021\/acs.biomac.7b00158","article-title":"Protein corona formation on colloidal polymeric nanoparticles and polymeric nanogels: impact on cellular uptake, toxicity, immunogenicity, and drug release properties","volume":"18","author":"Obst","year":"2017","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.ejpb.2022.01.009_b0160","doi-asserted-by":"crossref","first-page":"10764","DOI":"10.1021\/acs.langmuir.5b02158","article-title":"Stealth effect of biomolecular corona on nanoparticle uptake by immune cells","volume":"31","author":"Caracciolo","year":"2015","journal-title":"Langmuir"},{"key":"10.1016\/j.ejpb.2022.01.009_b0165","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.actbio.2021.11.034","article-title":"Physicochemical properties of nanoparticles affecting their fate and the physiological function of pulmonary surfactants","volume":"140","author":"Liu","year":"2022","journal-title":"Acta Biomater."},{"key":"10.1016\/j.ejpb.2022.01.009_b0170","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.jcis.2019.02.088","article-title":"Qualitative and quantitative analysis of the biophysical interaction of inhaled nanoparticles with pulmonary surfactant by using quartz crystal microbalance with dissipation monitoring","volume":"545","author":"Wan","year":"2019","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.ejpb.2022.01.009_b0175","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.atmosenv.2016.06.031","article-title":"Determination of the bioaccessible fraction of metals in urban aerosol using simulated lung fluids","volume":"140","author":"Coufal\u00edk","year":"2016","journal-title":"Atmos. Environ."},{"key":"10.1016\/j.ejpb.2022.01.009_b0180","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0378-5173(03)00091-7","article-title":"A novel method for assessing dissolution of aerosol inhaler products","volume":"255","author":"Davies","year":"2003","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2022.01.009_b0185","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.addr.2015.09.012","article-title":"PEGylation as a strategy for improving nanoparticle-based drug and gene delivery","volume":"99","author":"Suk","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2022.01.009_b0190","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.actbio.2020.12.061","article-title":"Inhalable PLGA microspheres: tunable lung retention and systemic exposure via polyethylene glycol modification","volume":"123","author":"Li","year":"2021","journal-title":"Acta Biomater."},{"key":"10.1016\/j.ejpb.2022.01.009_b0195","first-page":"542","article-title":"Pharmacokinetics of a ternary conjugate based pH-responsive 10-HCPT prodrug nano-micelle delivery system","volume":"12","author":"Liu","year":"2017","journal-title":"Asian J. Pharm. Sci."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641122000157?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641122000157?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T16:47:27Z","timestamp":1760546847000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641122000157"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":39,"alternative-id":["S0939641122000157"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2022.01.009","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Elucidating inhaled liposome surface charge on its interaction with biological barriers in the lung","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2022.01.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}